Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 38 Pancreatic Neoplasms 16 Colonic Neoplasms 12 Rectal Neoplasms 11 Stomach Neoplasms 9 Neoplasms 9 Neuroblastoma 8 Small Cell Lung Carcinoma 7 Rhabdomyosarcoma 7 Neoplasm Metastasis 7 Glioblastoma 7 Sarcoma, Ewing 6 Gastrointestinal Neoplasms 6 Central Nervous System Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Glioma 5 Sarcoma 4 Brain Neoplasms 4 Medulloblastoma 3 Intestinal Neoplasms 3 Gliosarcoma 3 Gastrointestinal Diseases 3 Esophageal Neoplasms 3 Digestive System Neoplasms 3 Digestive System Diseases 3 Astrocytoma 3 Advanced Solid Tumors 3 Recurrence 2 Rectal Diseases 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2

Interventions

apatinib 3 camrelizumab 2 Paclitaxel 2 Irinotecan 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced Gastric Cancer × Irinotecan × Clear all

NCT01136031 2015-05-20

TI-2ndAGC

Seoul National University Hospital

Phase 1/2 Completed

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡